Equity Profile

SOLV

Solventum Corporation

Health CareHealth Care Supplies$14.7B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Solventum Corporation operates in the health care supplies sector, providing essential products that support medical and health-related needs. With a market cap of $15 billion, the company plays a vital role in the healthcare supply chain, which is increasingly important as demand for healthcare services continues to grow.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company has performed compared to expectations.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand in the healthcare sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1 2026, Solventum reported an EPS of $1.48, beating estimates by 9.39%. The stock reacted positively, gaining 2.37% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given Solventum's strong track record of beating EPS estimates. However, the lack of guidance raises uncertainty about future performance.

Bull Case

If Solventum continues its trend of beating EPS estimates, it could see significant stock price appreciation, especially if revenue growth is also strong.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Solventum's history of beating EPS estimates, the market will closely watch this figure to gauge ongoing profitability.

How is revenue growth trending compared to previous quarters?

Revenue growth is crucial for assessing the company's ability to capitalize on market demand and sustain its competitive edge.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Solventum's ability to outperform due to its strong historical EPS performance and the growing demand for healthcare supplies.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, indicating strong operational performance.

Options pricing suggests a significant move, indicating that traders expect volatility, which could favor a positive outcome.

The healthcare sector is experiencing growth, which may not be fully reflected in current market expectations.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment in favor of Solventum.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Solventum can maintain its strong performance in a competitive healthcare landscape.

Bull Confirmed If

An EPS of $1.60 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $1.35 would confirm the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests a potential stock increase of around 1.14%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 2.08%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in healthcare supplies.
2Management's commentary on market demand and competitive positioning.
3Insights into cost management and supply chain efficiency.
4Guidance on future revenue growth and profitability expectations.
5Any changes in regulatory impacts affecting the healthcare supplies industry.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company has performed compared to expectations.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand in the healthcare sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1 2026, Solventum reported an EPS of $1.48, beating estimates by 9.39%. The stock reacted positively, gaining 2.37% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Solventum continues its trend of beating EPS estimates, it could see significant stock price appreciation, especially if revenue growth is also strong.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Solventum's history of beating EPS estimates, the market will closely watch this figure to gauge ongoing profitability.

How is revenue growth trending compared to previous quarters?

Revenue growth is crucial for assessing the company's ability to capitalize on market demand and sustain its competitive edge.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Solventum's ability to outperform due to its strong historical EPS performance and the growing demand for healthcare supplies.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, indicating strong operational performance.

Options pricing suggests a significant move, indicating that traders expect volatility, which could favor a positive outcome.

The healthcare sector is experiencing growth, which may not be fully reflected in current market expectations.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment in favor of Solventum.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Solventum can maintain its strong performance in a competitive healthcare landscape.

Bull Confirmed If

An EPS of $1.60 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $1.35 would confirm the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests a potential stock increase of around 1.14%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 2.08%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in healthcare supplies.
2Management's commentary on market demand and competitive positioning.
3Insights into cost management and supply chain efficiency.
4Guidance on future revenue growth and profitability expectations.
5Any changes in regulatory impacts affecting the healthcare supplies industry.